About this trial
This study evaluates a new single-beat echocardiographic technique (TE-e', the time difference between the onset of the mitral inflow E wave and the septal e' wave on tissue Doppler imaging) for estimating left atrial pressure (LAP) in critically ill patients, comparing it against the standard two-beat method. The goal is to determine whether the faster, single-beat method gives results as reliable as the conventional method, and whether it can help identify patients with elevated left atrial pressure without an invasive procedure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients ≥18 years admitted to the QMH Adult Intensive Care Unit (AICU)
Requiring a transthoracic echocardiogram (TTE) as part of routine clinical care
TE-e' obtainable by both the conventional and the novel method
Disqualifiers
Patients <18 years of age
Patients in atrial fibrillation
Patients with a poor TTE acoustic window
Patients in whom TE-e' is technically difficult to obtain or interpret by either method
Trial population
Patients admitted to Adult Intensive Care Unit requiring a TTE
Trial design
Cohort
Prospective
Treatments tested in this trial
Echocardiography
Diagnostic testFull echocardiogram performed on recruited patients.
Treatment groups
Trial outcomes
Primary outcomes
Correlation between novel (single-beat) and conventional (two-beat) TE-e' values
Secondary outcomes
Correlation between novel and conventional methods in obtaining septal e' and s' velocities - At time of index TTE
Correlation between clinical evaluation of LAP and TE-e' value
Correlation between other echocardiographic parameters of LAP (E/A ratio, LAVi, TR Vmax, lung ultrasound 6-point protocol) and TE-e' value
Sponsors and contacts
Click on the lead sponsor to view all of their trials.